Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-24T17:26:58.253Z Has data issue: false hasContentIssue false
  • English
  • Français

BCG vaccination of children against leprosy in Uganda: final results

Published online by Cambridge University Press:  25 March 2010

Susan J. Stanley ,
C. Howland ,
M. Mary Stone  and
I. Sutherland
Susan J. Stanley
Affiliation:
MRC Biostatistics Unit, Medical Research Council Centre, Hills Road, Cambridge CB2 2QH
C. Howland
Affiliation:
MRC Biostatistics Unit, Medical Research Council Centre, Hills Road, Cambridge CB2 2QH
M. Mary Stone
Affiliation:
MRC Biostatistics Unit, Medical Research Council Centre, Hills Road, Cambridge CB2 2QH
I. Sutherland
Affiliation:
MRC Biostatistics Unit, Medical Research Council Centre, Hills Road, Cambridge CB2 2QH
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A total of 19200 children, all contacts or relatives of known leprosy patients, and all free of visible leprosy lesions, were included in a controlled trial of BCG vaccination against leprosy in Uganda between 1960 and 1964. They were followed for an average of 8 years, during which time 261 developed early leprosy lesions. A less comprehensive follow-up was carried out for a further 5 years, when 8 more cases of leprosy were identified.

In the main intake, between 1960 and 1962, 16150 tuberculin-negative or weakly tuberculin-positive (Heaf Grades O-II) children were allocated by an effectively random process to either a BCG-vaccinated or an unvaccinated control group. Both groups were seen and examined in an identical fashion for leprosy at approximately 2-year intervals, and precautions were taken to ensure unbiased assessment of new cases of leprosy. After 8 years, 41 cases of leprosy had been identified in the BCG-vaccinated group, and 201 in the control group, a percentage reduction in the BCG-vaccinated group compared with the control group of 80%. The percentage reduction was similar for those initially tuberculin-negative, and for those initially weakly positive, and did not depend upon the age at vaccination. It was also similar for both sexes, for contacts of lepromatous and contacts of non-lepromatous leprosy, for children having contact with one or more than one patient, and for differing grades of physical contact and genetic relationship with a patient. The protective effect of BCG vaccination continued over the 8-year period, although it may have fallen off slightly at the end.

In a group of 1074 strongly tuberculin-positive (Heaf Grades III-IV) children followed in parallel with the other two groups a total of 16 cases of leprosy were identified. When adjusted for age, this incidence is 58% lower than that in the unvaccinated control children who were initially tuberculin-negative, indicating a protective effect against leprosy of naturally-acquired strong tuberculin sensitivity.

Between 1970 and 1975, one new case of leprosy was identified in a child who had initially been strongly tuberculin-positive and had therefore not been vaccinated, one in a BCG-vaccinated child, and 6 in control children. Although the follow-up in this period was less comprehensive than that in the main part of the trial, the ascertainment of cases was unlikely to have been biased towards either vaccinated or control children. These results indicate a continuing protective effect of BCG up to 12–13 years after vaccination.

Type
Research Article
Information
Journal of Hygiene , Volume 87 , Issue 2 , October 1981 , pp. 233 - 248
Copyright
Copyright © Cambridge University Press 1981

References

Bechelli, L. M., Garbajosa, G. P., Engler, V., Dominguez, M. V., Paredes, L., Koch, G., Uemura, K. & Sundaresan, T. (1968). BCG vaccination of children against leprosy – preliminary results of W.H.O. trial in Burma. International Journal of Leprosy 36. 573.Google Scholar
Bechelli, L. M., Garbajosa, G., Uemura, K., Engler, V., Dominguez, V. M., Paredes, L., Sundaresan, T., Koch, G. & Matejka, M. (1970). BCG vaccination of children against leprosy. Preliminary findings of the W.H.O.-controlled trial in Burma. Bulletin of the World Health Organization, 42, 235–281.Google ScholarPubMed
Bechelli, L. M., Garbajosa, P. G., Gyi, M. M., Uemura, K., Sunaresan, T., Dominguez, V. M., Matejka, M., Tamondong, C., Quagliato, R., Engler, V. & Altmann, M. (1973). BCG vaccination of children against leprosy: Seven-year findings of the controlled W.H.O. trial in Burma. Bulletin of the World Health Organization 48, 323–334.Google Scholar
Bechelli, L. M., Lwin, K., Garbajosa, P. G., Gyi, M. M., Uemura, K., Sundaresan, T., Tamondong, C., Matejka, M., Sansarricq, H. & Walter, J. (1974). BCG vaccination of children against leprosy: Nine-year findings of the controlled W.H.O. trial in Burma. Bulletin of the World Health Organization 51. 93–99.Google Scholar
Brown, J. A. K. (1955). The incidence and epidemiology of leprosy in Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene 49, 241–52.CrossRefGoogle ScholarPubMed
Brown, J. A. K. (1959). Factors influencing the transmission of leprosy. International Journal of Leprosy 27, 250–60.Google Scholar
Brown, J. A. K. & Stone, M. M. (1966). BCG vaccination of children against leprosy: first results of a trial in Uganda. British Medical Journal i. 7–14.CrossRefGoogle Scholar
Brown, J. A. K., Stone, M. M. & Sutherland. I. (1968). BCG vaccination of children against leprosy: results at end of second follow-up. British Medical Journal i, 24–27.CrossRefGoogle Scholar
Brown, J. A. K., Stone, M. M. & Sutherland, I. (1969). Trial of BCG vaccination against leprosy in Uganda. Leprosy Review 40, 3–7.CrossRefGoogle ScholarPubMed
Comstock, G. W., Livesay, V. T. & Woolpert, S. F. (1974). Evaluation of BCG vaccination among Puerto Rican children. American Journal of Public Health 64, 283–291.CrossRefGoogle ScholarPubMed
Comstock, G. W. & Webster, R. G. (1969). Tuberculosis studies in Muscogee County, Georgia VII. A twenty-year evaluation of BCG vaccination in a school population. American Review of Respiratory Disease 100, 839–845.Google Scholar
Comstock, G. W., Woolpert, S. F. & Livesay, V. T. (1976). Tuberculosis studies in Muscogee County Georgia, Twenty-year evaluation of a community trial of BCG vaccination. Public Health Reports 91, 276–280.Google ScholarPubMed
Medical Research Council (1972). BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. (Fourth report). Bulletin of the World Health Organization 46, 371–385.Google Scholar
Palmer, C. G. & Edwards, L. B. (1968). Identifying the tuberculous infection. The dual-test technique. JAMA 205. 117–119.CrossRefGoogle Scholar
Rook, G. A. W., Bahr, G. M. & Stanford, J. L. (1981). The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle 62, 63–68.CrossRefGoogle ScholarPubMed
Russell, D. A., Scott, G. C. & Wigley, S. C. (1964). BCG vaccination in leprosy. A preliminary report of a ‘blind’ controlled trial. International Journal of Leprosy 32. 235–247.Google ScholarPubMed
Russell, D. A. (1973). BCG vaccination in the prophylaxis of leprosy. The Karimui leprosy research group. In Abstracts of the Tenth International Leprosy Congress, Bergen, 1973, p. 135, Abstract no. 7/221.Google Scholar
Scott, G. C., Wigley, S. C. & Russell, D. A. (1968). The epidemiology of leprosy – the Karimui trial. International Journal of Leprosy 36. 573.Google Scholar
Stanford, J. L., Shield, M. J. & Rook, G. A. W. (1981). How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle 62, 55–62.CrossRefGoogle ScholarPubMed
Tuberculosis Prevention Trial, Madras (1980). Trial of BCG vaccines in South India for tuberculosis prevention. Indian Journal of Medical Research 72. Suppl. 1–74.Google Scholar
White, S. J., Stone, M. M. & Howland, C. (1978). Genetic factors in leprosy: a study of children in Uganda. Journal of Hygiene, Cambridge 80, 205–216.CrossRefGoogle ScholarPubMed